2022 Access DEA Topical 
Canna Law Blog
MAY 1, 2024
I take issue with some of the headlines , so here’s mine: “DEA Reportedly Agrees to Initiate Proposed Rulemaking to Reschedule Marijuana…”. In October of 2022, President Biden requested that the Department of Health and Human Services (HHS) review marijuana’s placement on Schedule I of the Controlled Substances Act (CSA).
Canna Law Blog
NOVEMBER 3, 2023
If you had that impression, it may be because reporting on this topic has been subpar. They would get similar access to banking, SBA loans, and federal tax treatment, for starters. They’ve also been thinking about this for a while – I actually previewed this filing with Andrew Smith back in June of 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kind Meds (Cannabis Education Blog)
FEBRUARY 7, 2022
Review our compilation of cannabis trends for 2022 to stay up to date on the latest news in the cannabis industry and ensure you are prepared for the future. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.
Cannabis Law Report
AUGUST 6, 2021
Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).
Cannabis Law Report
MAY 29, 2022
Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. 1] Letter from Sens. 2] David E.
Veriheal
AUGUST 24, 2022
In a statement to The Denver Post, Natural Medicine Colorado—which sponsored the act—said “the measure is designed to prioritize mental health and healing, while balancing safety and access.” ” The spokesperson added, “Those are the sole motivations for the design of the initiative.
Project CBD
AUGUST 23, 2023
Marketing to Minors Unlike state-regulated cannabis, this new wave of acutely intoxicating substances is easily accessible to minors. There must be a concerted effort by the FDA and DEA to address the public health crisis spawned by the proliferation of unregulated designer drugs being sold under the guise of hemp.
Expert insights. Personalized for you.
88 
Let's personalize your content